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Brief Report
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The common sense model (CSM) of illness representations provides a theoretical framework that explains how illness perceptions guide individuals’ helpful or unhelpful attempts to cope with an illness threat (Leventhal, Meyer, & Nerenz, 1980; Leventhal, Nerenz, & Steele, 1984). Previous research suggests that illness representations can be primed outside of conscious awareness (Henderson et al., 2009). The present study assesses if implicitly activating illness representations of “headache”, subsequently activates coping procedures, and examines the interaction with illness treatment beliefs.
Many studies have tested the CSM and shown that unhelpful or negative illness perceptions predict poor outcomes (Meuleman et al., 2015; Crawshaw et al., 2015). To explain how illness representations, influence health outcomes, Leventhal et al. (1980) suggest that illness representations are schematic representations, located subconsciously as an illness “prototype”. “Prototypes” can be implicitly activated (Henderson et al., 2007, 2009; Williams, Wasserman, and Lotto, 2003; Orbell, Henderson and Hagger, 2015) and lead to an automatic activation of coping processes. For example, Henderson, Orbell, and Hagger (2009) observed that participants primed for “flu” and who were frequent users of medication to control flu symptoms, showed an attentional bias to such medications (“Lemsip” and “Lozenge,”). In accordance with the CSM, these findings suggest that illness representations can be implicitly activated outside of consciousness and may activate specific coping mechanisms. 





The relationship between illness schema activation and attentional engagement to the coping related word (“Paracetamol”) was assessed using a 2 (primed vs. control) x 2 (strong belief in medication efficacy vs. weak belief in medication efficacy) experimental design. Response time (latency) to the target word “Paracetamol” was the primary outcome.

Participants
Participants were adult native English speakers recruited through advertisements through King’s College London, social media, and poster adverts. Participants were informed that this study was examining cognitive processes in word reading to reduce expectation effects. University ethical approval was granted. Consented participants were randomly allocated to either the prime or control condition via www.randomizer.org (​http:​/​​/​www.randomizer.org​). 
Sixty-three participants were recruited to the experiment (prime n=33; control n=30). A summary of participant characteristics is shown in Table 1. Participant characteristics did not differ between the two conditions.

Selecting the stimulus target word (dependent variable) 
	In a pilot study, 87 native English language speaking undergraduates, were asked, “Please list, in rank order, the top 10 single words that you believe are associated with coping with a headache.” 56 (64%) listed “paracetamol” as the word they believe is most associated with coping with a headache. Paracetamol is a commonly used analgesic (painkiller), typically available without prescription. Paracetamol was used as the target word within the grammatical decisions task described below.

Priming procedure
	This experiment used E-Prime software delivered on a Dell 2009 Laptop. A subliminal prime was embedded within a grammatical decision task. Participants were randomized into an illness-primed experimental group, whereby the word “Headache” was shown for 17ms; or a control group, whereby ““XXXXXXXX” appeared for 17ms. In both conditions the prime was proceeded and followed by a random letter sting mask (XBFBZRMQWBX) for 60ms. 

The grammatical decision task procedure
Response engagement to the target word “Paracetamol” was indicated by response latency as part of a grammatical decision task undertaken by both experimental and control groups. Following priming, participants were presented with twelve words in addition to the target word “Paracetamol”; their task was to categorize each word as either a verb (6) or non-word (6) by pressing keys ‘A’ or ‘L’ as quickly and accurately as possible. These 6 words were repeated in a random over three trials.  Words were matched for frequency of use and length using the Celex database (Baayen, Piepenbrock, & van Rijn, 1993). Before completing the grammatical decision task with the incorporated target words, participants completed a practice trial. 
Response latency to the target word “Paracetamol” was measured in milliseconds. The average response latency across the three main trials was used as the dependent measure.

Illness perceptions
	The Brief Illness Perceptions Questionnaire (BIPQ) was used to illness perceptions (Broadbent et al., 2006). The BIPQ treatment control item: “How much do you think paracetamol can help your headache?” was used to dichotomize the sample into those with high or low treatment control beliefs. Participants who recorded a score of 0 (not helpful at all) to 4 were labelled as having weak efficacy/control beliefs. Participants who reported a score of 5 to 10 (extremely helpful) were labelled as having high efficacy/control beliefs. 

Demographic data
Demographic information including: age, gender, and ethnicity. Participants indicated whether they were in any physical pain (headache or other) in order to exclude any participants in current pain at the time of testing.

Statistical Analysis




One participant was excluded after indicating the presence of pain. Another was excluded since their mean response latency was an outlier. No participants made greater than 6% errors on the task. The total analysed sample size was 61 (prime=32; control=29).
Seventeen participants were categorised as having low efficacy/treatment control belief, and forty-four participants as having high efficacy/treatment control beliefs.

Experimental effects
Means latencies for each condition are shown in Table 2. Mean response latency did not differ significantly between illness-prime and control conditions [F(1, 57) = 0.03, p = 0.87,  ηp2=0.001], suggesting no main effect of the condition upon response engagement. Furthermore, mean response latency did not differ significantly between those with high or low paracetamol treatment beliefs [F(1,57)= 2. 54, p = 0.12, ηp2= 0.04]. However, there was a significant group interaction effect between the experimental (vs. control) conditions and paracetamol treatment beliefs (high vs. low) [F (1,57) = 22.30, p < 0.001; ηp2= 0.28]. 
Post hoc analyses showed that within the experimental group, those with high treatment control beliefs had a greater response latency to “paracetamol” compared to those with low control beliefs (p<0.01). Within those with high control beliefs, illness-primed participants showed a significantly greater response latency to the target word “paracetamol”, compared to the control group (p<0.01).
Within the control group there was no difference in mean response latency between those with high and low treatment control beliefs (p=0.21). In those with low control beliefs, there was no difference between the experimental and control groups (p=0.058).
Discussion
This study evaluated whether implicit activation of headache illness schema would result in an attention disengagement effect to pain relief medication, moderated by treatment control beliefs. Our findings support our hypothesis and are consistent with Henderson et al, (2007; 2009). Our findings suggest that use of coping procedures can become encoded within illness schema providing further support for the theoretical assumptions of the CSM. 

Effects of the headache prime on mediation related coping behaviours
We observed no main effect for the prime. One possible explanation of these findings is that high efficacy of treatment, rather than just knowledge of the coping strategy, is necessary for the behaviour to become embedded within the illness schema. This reasoning is consistent with our hypothesis, as only participants who were primed with the illness schema “headache” and who perceived paracetamol to be a useful coping strategy showed an attentional disengagement effect. Given the sample consisted of healthy participants with no reported pain at the time of the experiment, this study could facilitate a priming effect without any indication of explicit illness schema activation. 
Limitations
A few limitations are worthy to note. Firstly, the number of participants with weak treatment control perceptions was small. Secondly we relied on reaction times as an indirect indicator of response engagement. Recent studies have suggested that measuring eye movements is a more accurate methodology to measure for attentional bias/response engagement (Fashler and Katz, 2014). 
Conclusion
The present study replicates past findings and supports the assumptions of the CSM showing that coping processes are embedded within illness schema. Larger studies are now needed to further test the hypothesis examined here in order to better understand the implicit coping processes associated with illness schema.
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Table 1: Demographic characteristics of the randomised participants 
	Primecondition(n=33)	Control condition(n=30)	Full Sample(N= 63)	Statistic
Age (years, mean, s.d)	35.4 (15.15)	31.9 (14.7)	33.8 (14.9)	t(61)= 0.91 p=0.37
Gender       Female, n (%)       Male, n (%)	21 (63.6)12 (36.4)	23 (76.7)7 (23.3)	44 (69.8)19 (30.2)	Χ2=1.27 p=0.26
Ethnicity      White, n (%)      Non-white, n (%)	18 (54.5)15 (45.5)	21 (70.0)9 (30.0)	39 (61.9%)24 (38.1%)	Χ2=1.59 p=0.21
Paracetamol treatment control      High, n (%)      Low, n (%)	26 (78.8)7(21.2)	22 (73.3)8 (26.7)	48 (76.2)15 (23.8)	Χ2=0.26 p=0.61
 








Table 2: Mean response latencies for the target word (“Paracatemol”) across conditions
	Target word response latency (ms)1




Note. M; Mean.  SD; Standard deviation 
n = cell (group) sample size
1Mean latency response across 3 trials.
Analysed sample n=61
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